🇺🇸 FDA
Patent

US 11091534

Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof

granted A61KA61K38/00A61K38/36

Quick answer

US patent 11091534 (Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOVERATIV THERAPEUTICS INC.
Grant date
Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K38/36, A61K38/37, A61K47/55